Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) Shares Outstanding (Diluted Average) (2016 - 2021)

Bio-Techne has reported Shares Outstanding (Diluted Average) over the past 12 years, most recently at $41.2 million for Q4 2021.

  • For Q4 2021, Shares Outstanding (Diluted Average) rose 2.67% year-over-year to $41.2 million; the TTM value through Dec 2021 reached $41.2 million, up 2.67%, while the annual FY2021 figure was $40.5 million, 2.75% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2021 was $41.2 million at Bio-Techne, roughly flat from $41.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $41.2 million in Q4 2021 and troughed at $37.5 million in Q1 2017.
  • A 5-year average of $39.2 million and a median of $39.1 million in 2019 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 0.47% in 2017 and later rose 3.36% in 2021.
  • Year by year, Shares Outstanding (Diluted Average) stood at $37.9 million in 2017, then grew by 2.17% to $38.7 million in 2018, then rose by 2.07% to $39.6 million in 2019, then increased by 1.48% to $40.1 million in 2020, then rose by 2.67% to $41.2 million in 2021.
  • Business Quant data shows Shares Outstanding (Diluted Average) for TECH at $41.2 million in Q4 2021, $41.2 million in Q3 2021, and $40.5 million in Q2 2021.